Twin Securities’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History

Twin Securities’s Portfolio RARX Stock Details RARX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-111,614	Closed	-$5.36M	–	20
2020 Q1	$5.36M	Buy	+111,614	New	+$5.19M	2.74%	7

Other funds holding RARX

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Twin Securities's RARX Position: Q2 2020 in Review

Twin Securities sold out of Ra Pharmaceuticals, Inc. Common Stock (RARX) in Q2 2020, closing a stake of 111,614 shares — an estimated $5.36M sold.

Twin Securities first reported a position in RARX in Q1 2020 and held it in 1 quarter. The position peaked at $5.36M in Q1 2020. 1 fund tracked by Wall St. Rank holds RARX as of Q2 2020.

Twin Securities reported no remaining Ra Pharmaceuticals, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
Twin Securities sold 111,614 Ra Pharmaceuticals, Inc. Common Stock shares in Q2 2020, an estimated $5.36M.
Twin Securities first reported a position in Ra Pharmaceuticals, Inc. Common Stock in Q1 2020 and held it in 1 quarter.
Twin Securities's Ra Pharmaceuticals, Inc. Common Stock position peaked at $5.36M in Q1 2020.
1 fund tracked by Wall St. Rank held Ra Pharmaceuticals, Inc. Common Stock as of Q2 2020.

Based on Twin Securities's 13F filing for Q2 2020, filed 14 Aug 2020.